Funding Cutting-Edge Research
and Educational Outreach

The Glaucoma Foundation is dedicated to developing a cure for glaucoma through innovative research, collaboration and education. Our goal is to eradicate blindness caused by glaucoma.

About Glaucoma

Educate yourself on the eye and how it works, diagnosing glaucoma, exfoliation syndrome, and glaucoma treatments.

Living with Glaucoma

People deal differently with their glaucoma diagnosis and the reality of living with a chronic disease.
Read their stories.


The Glaucoma Foundation has been funding groundbreaking glaucoma research for over 30 years.

September 1, 2020

A Message from TGF’s President & CEO Elena Sturman

The times continue to be challenging. But we want you to know that TGF has been hard at work, with a special focus on our research program.

Each year, TGF awards seed grants for innovative projects that provide a platform for large and impactful research advances. We recently announced a new granting platform focused on the topic of intraocular pressure-independent mechanisms of optic nerve degeneration in glaucoma. Examples of research that may be considered for these one-year grants of $60,000 range from basic science to clinical interventions, such as genetics and genomic medicine, disease modeling, assessment of ocular perfusion, artificial intelligence, and clinical research.

On the funding side, we are in the midst of The TGF Art Challenge to Celebrate Vision, with artists and art lovers participating to support our research program. Please visit our art gallery to learn more!

It’s not too late to become a visionary for vision.

Click here to read more…

Sign up for our newsletter, and stay informed.

Your donation matters.

Since it’s founding in 1984, The Glaucoma Foundation has never wavered from its principle mission: to fund cutting edge glaucoma research and to educate the public about glaucoma, its diagnosis, and its treatment. The support of individuals like you has provided us with the resources to deliver on this mission.

Sign up for our newsletter, and stay informed.